Introduction
Halogenated aliphatics are widely used as chemical intermediates and solvents and are potential environmental pollutants. It has been shown that some of them, particularly the brominated and chlorinated hydrocarbons are readily metabolized to reactive products that can interact with nucleic acids and proteins (1). 1,2-Dibromoethane (1,2-DBE*) and 1,1,2,2-tetrachloroethane (1,1,2,2-TTCE) are two of the most representative compounds among the smallest haloalkanes. 1,2-DBE was until recently largely used as insecticide, fumigant and as lead scavenger in gasoline. It is carcinogenic for animals and
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can be considered one of the most potentially carcinogenic halogenated aliphatic hydrocarbons which humans are exposed to. For this reason its commercial use has been restricted. Although there are a lot of data on its mutagenic ability, the role of 1,2-DBE in carcinogenesis process is as yet unknown (2) .
1,1,2,2-TTCE is used as solvent and chemical intermediate for trichloroethylene production. It is considered the most toxic among the smaller chlorinated compounds (3) . Results from rodent bioassays showed that 1,1,2,2-TTCE induced significant increase of hepatocarcinomas in B6C3F1 mice of both sexes, a strain genetically susceptible to develop liver tumour (2) (3) (4) . Few data from short-term tests gave evidence for mutagenic activity of this compound (5) .
We have previously found that both 1,2-DBE and 1,1,2,2-TTCE managed to react covalently with rodent liver DNA to a very similar extent (6) (7) (8) and covalent binding index values (CBI), calculated according to Lutz (9) , closely resembled those of compounds acting as moderate initiators in multistep carcinogenesis. Both of them also succeeded in transforming BALB/c 3T3 cells, 1,2-DBE being more potent in inducing cell transformation (10, 11) . In the two-stage transformation assay 1,2-DBE and 1,1,2,2-TTCE were found to act as initiators of cell transformation event (12, 13) . 1,1,2,2-TTCE was also examined in a rat liver assay for tumour initiating and promoting activities and was found to induce significant increases in GGT+ foci only when administered in the promotion protocol (14) .
In the aim to verify the possible role of these two haloalkanes as promoters of tumour process, we have tested both of them in the modified two-stage cell transformation test where cells have been initiated with subtransforming doses of noted carcinogens and then exposed to chronic treatment with non transforming dosages of 1,2-DBE and 1,1,2,2-TTCE. The in vitro transformation test in BALB/c 3T3 cells is considered to rather resemble the multistage carcinogenesis process in vivo (15) and it can be regarded as a useful short-term test to detect the transforming potential also of non genotoxic compound (16) .
Material and methods
Chemicals 1,2-DBE (98% pure) and 12-0-tetradecanoylphorbol 13-acetate (TPA) were purchased from Sigma Chemical Co., (St Louis, MO). 1,1,2,2-TTCE (98% pure), 3-methylcholanthrcne (3-MCA), W-methyl-AZ-nitro-yV-nitrosoguanidine (MNNG) were obtained from Fluka, Switzerland.
Cells and cell culture
The original stock of BALB/c 3T3 cells, clone A31, was obtained from American Type Culture Collection, Rockville, MD. Working cultures were expanded from the original cryoprcserved stock. Cells were grown in Dulbecco's modified Eagle's medium (D-MEM from GD3CO) supplemented with 10% newborn calf serum (GD3CO) and in the absence of antibiotics. Only subconfluent cells, 60-70% confluent cultures, were used in the assay and the target cells were not maintained beyond the third passage after thawing.
Two-stage transformation assay
Exponentially growing cells were seeded at a density of 10* cells/60-mm dish (10-13 dishes for each treatment condition and 20-30 plates for negative and positive controls). Transformation was initiated 24 h later with 1 Hg/ml 3-MCA for 72 h or 1 ng/ml MNNG for 48 h, dissolved in 0.5% dimethylsulphoxide (DMSO) (initiating treatment). Cells were, then, washed with phosphate buffered saline (PBS) and replaced with fresh normal medium. Four days after and each time the medium was changed (twice weekly) the cultures were treated with medium containing 100 ng/ml TPA or the tested compounds at different concentrations until the end of experiment (promotion treatment). MNNG-initiated cells were exposed to seven different dosages of 1,2-DBE (from 0.1 to 1000 ng/rrU) or to nine doses of 1,1,2,2-TTCE (from 0.1 to 1000 ng/ml). 3-MCA-initiated cells were exposed to the same 1,2-DBE concentrations range and to a stricter range of 1,1,2,2-TTCE doses (six doses from 10 to 1000 ng/ml). Controls for spontaneous transformation were performed with untreated cells and solvent vehicle-treated cells (0.5% DMSOtreated cells). Positive controls were carried out with 2.5 |ig/ml 3-MCA. In the experiment performed with 3-MCA-initiated cells, a level-FI amplification test was done by replating 2X10 5 confluent cells from each treatment into 60-mm plate. Then, the cells were exposed again to the promotion treatment. Ten replicates were carried out. Five weeks after the treatment, level-I and level-U plates were fixed with methanol, stained with 10% aqueous Giemsa and scored for foci formation. Only foci considered as positive (15) , deeply basophilic, showing a dense layer formation and a random orientation of cells at the edges of foci, and not smaller than 1 mm were counted. Values were reported as number of positive plates (plates with fociyplates scored, mean number of foci per plate, total number of foci per each treatment and transformation frequency (TF) calculated on the cells at risk after chemical treatment. Colony-forming efficiency was verified in parallel with the transformation test by seeding 100 cells/60-mm plates in five replicates. Cells were treated with 3-MCA or MNNG and with 100 ng/ml TPA or different doses of tested compounds, the same doses as in the transformation assay, from 3 days after removal of initiators. The cultures were fixed and stained with 10% Giemsa 10 days after seeding and colonies of at least 50 cells were counted. Cytotoxicity was expressed as mean number of colonies obtained per dose level, clonal efficiency (CE) and as relative clonal efficiency with respect to solvent vehicle-treated cells.
Statistical analysis
Statistical evaluation of foci distribution was performed by the Mann-Whitney unpaired (-test. The significant percentage of plates with foci with respect to scored plates was calculated according to the Fisher-Yates test of significance in 2X2 contingency tables. The TF was analysed by the comparison of Poisson rates, after verifying that TF values fit a Poisson distribution. Significant differences in the clonal efficiency of cells exposed to different treatments were tested by the z test for comparison of two proportions. Doseresponse relationships were analysed by linear regression analysis and by the Cochran-Armitage normal deviate test for trend. Table I shows the clonal efficiency of the cells initiated with MNNG and exposed to the promoting treatment with 1,2-DBE or 1,1,2,2-TTCE. Results are reported as the average of four independent cytotoxicity tests. The clonal efficiency in the cells initiated with MNNG and exposed to 1,2-DBE resulted markedly reduced. Dose-response positive trend was shown (P < 0.01 at the Cochran-Armitage normal deviate test for trend). The cytotoxicity in the plates exposed to 1,1,2,2-TTCE promoting treatment linearly increased with the assayed dosage of the compound {P < 0.05 at the linear regression analysis). At the lowest doses, 1,1,2,2-TTCE significantly enhanced the clonal efficiency whereas at the highest doses the number of surviving cells were slightly reduced. Table II shows results on the transformation rate from the experiment performed with MNNG-initiated cells exposed to promoting treatment with 1,2-DBE and 1,1,2,2-TTCE. In the case of 1,1,2,2-TTCE, results obtained at the dosages of 10 and 50 ng/ml are the average of three different experiments, results obtained at the dosages of 100 and 1000 ng/ml are the mean of two different experiments. The employed dose of MNNG resulted as a subtransforming dose for the cells. Less than half the plates treated with MNNG alone were scored as positive. Foci distribution and TF were not significantly different from that observed in the negative controls (untreated cells and DMSO-treated cells). When MNNG-treated cells were exposed to the promoting treatment with TPA, transformed foci were obtained in all plates, foci distribution was highly significant and the TF value was more than six times higher than that obtained as a consequence of spontaneous transformation and five times higher than that scored in MNNG-treated Clonal efficiency (CE) C None 0.5 % DMSO ng/ml MNNG ng/ml MNNG + Hg/ml MNNG + ng/ml MNNG + Hg/ml MNNG + Hg/ml MNNG + Hg/ml MNNG + ng/ml MNNG + ng/ml MNNG + ng/ml MNNG + ng/ml MNNG + ng/ml MNNG + ng/ml MNNG + ng/ml MNNG + ng/ml MNNG + ng/ml MNNG + ng/ml MNNG + MNNG + 100 ng/ml TPA 0.1 ng/ml 1,2-DBE 1 ng/ml 1,2-DBE 10 ng/ml 1,2-DBE 50 ng/ml 1,2-DBE 100 ng/ml 1,2-DBE 500 ng/ml 1,2-DBE 1000 ng/ml 1,2-DBE 0.1 ng/ml 1,1,2,2-TTCE 1 ng/ml 1,1,2,2-TTCE 5 ng/ml 1,1,2,2-TTCE 10 ng/ml 1,1,2,2-TTCE 50 ng/ml 1,1,2,2-TTCE 100 ng/ml 1,1,2,2-TTCE 250 ng/ml 1,1,2,2-TTCE 500 ng/ml 1,1,2,2-TTCE 1000 ng/ml 1,1,2,2-TTCE Enhancement of BALB/c 3T3 cell transformation by 1,2-dlbromoethane Table II . Promoting effects of 1,2-DBE and 1 Treatment None 0.5 % DMSO 1 ng/ml MNNG 1 ng/ml MNNG + 100 ng/ml TPA 1 ng/ml MNNG + 0.1 ng/ml 1,2-DBE 1 ng/ml MNNG + 1 ng/ml 1,2-DBE 1 ng/ml MNNG + 10 ng/ml 1,2-DBE 1 ng/ml MNNG + 50 ng/ml 1,2-DBE 1 ng/ml MNNG + 100 ng/ml 1,2-DBE 1 ng/ml MNNG + 500 ng/ml 1,2-DBE 1 ng/ml MNNG + 1000 ng/ml 1,2-DBE 1 ng/ml MNNG + 0.1 ng/ml 1,1,2,2-TTCE 1 ng/ml MNNG + 1 ng/ml 1,1,2,2-TTCE 1 ng/ml MNNG + 5 ng/ml 1,1,2,2-TTCE 1 ng/ml MNNG + 10 ng/ml 1,1,2,2-TTCE 1 ng/ml MNNG + 50 ng/ml 1,1,2,2-TTCE 1 ng/ml MNNG + 100 ng/ml 1,1,2,2-TTCE 1 ng/ml MNNG + 250 ng/ml 1,1,2,2-TTCE 1 ng/ml MNNG + 500 ng/ml 1,1,2,2-TTCE 1 ng/ml MNNG + 1000 ng/ml 1,1,2,2-TTCE Significantly different from 1 ng/ml MNNG-treated plates (P < 0.01) using distribution-free Mann-Whitney unpaired Mest. 'Significantly different from 1 ng/ml MNNG-treated plates (P < 0.001) at the comparison of Poisson rates.
Results
•Significantly different from 1 ng/m' MNNG-treated plates (P < 0.05) using distnbution-free Mann-Whitney unpaired (-test.
cells. 1,2-DBE promoting treatment induced a slight but significant increase of cell transformation in MNNG-initiated cells at almost all assayed dosages. TF values were three to five times higher than that of cells treated only with MNNG and all of them were significantly different from MNNGtreated cells. The transformation rate linearly increased with the applied dose up to 100 ng/ml (Figure 1 ). By contrast, 1,1,2,2-TTCE seemed not to affect cell transformation rate. Table m shows the clonal efficiency of BALB/c 3T3 cells initiated with 3-MCA and exposed to the promoting treatment with 1,2-DBE or 1,1,2,2-TTCE. The chronic treatment with 1,2-DBE induced a modest effect on cell clonal efficiency which was reduced by -20% with respect to that of DMSOtreated cells and 3-MCA-treated cells without any promoting treatment. The clonal efficiency was significantly reduced at all assayed doses of 1,2-DBE.
In Tables IV and V the effects of 1,2-DBE and 1,1,2,2-TTCE on the transformation rate of 3-MCA initiated cells are reported. In the standard transformation assay (level-I test) cells initiated with a sub-transforming dose of 3-MCA (1 |ig/ ml) gave rise to visible transformed foci only when exposed to the TPA promoting treatment. Cm the contrary, the treatment with 1,2-DBE or 1,1,2,2-TTCE did not increase the rate of cell transformation (Table IV) . When cells were allowed to perform further rounds of replication (level-II amplification test) a large fraction of 3-MCA-treated cultures gave rise to transformed foci when exposed to 1,2-DBE at any assayed dosage (Table V) . Only one dose of 1,1,2,2-TTCE (100 ng/ ml) seemed to have the same effect. This effect was confirmed in three independent experiments. A large number of transformed foci were also found in the plates treated with 2.5 \igl ml 3-MCA without promoting treatment (positive control). TPA treatment strongly increased the transformation yield of cells exposed to the subtransforming dose of 3-MCA (1 (ig/ ml). The amplification procedure did not significantly affect the rate of spontaneous transformation in untreated cells, DMSO-treated cells and in the target cells treated with 1 |ig/ ml 3-MCA.
Discussion
Promoting agents are thought to play a major role in the development of most human tumours, as humans live in an environment in which promoting substances are predominant (17) . It is also known that chemical agents acting only as initiators are difficult to identify. Many chemicals, although exerting their primary effects at one stage of the carcinogenesis process, may also play a role at a different stage, usually depending on the dose of the agent. This fact may be important for the evaluation of the risk associated with human exposure to a large number of substances at small concentrations but over a protracted, often lifelong, period of time.
A.Colacci tt al. Clonal efficiency (CE) C None 0.5% DMSO 1 Hg/ml 3-MCA 2.5 Hg/ml 3-MCA 1 Hg/ml 3-MCA + 1 Hg/ml 3-MCA 1 Hg/ml 3-MCA 1 Hg/ml 3-MCA 1 Hg/ml 3-MCA 1 Hg/ml 3-MCA 1 Hg/ml 3-MCA 1 Hg/ml 3-MCA 1 Hg/ml 3-MCA + 1 Hg/ml 3-MCA 1 Hg/ml 3-MCA 1 Hg/ml 3-MCA 1 Hg/ml 3-MCA 1 Hg/ml 3-MCA 100 ng/ml TPA 0.1 ng/ml 1,2-DBE 1 ng/ml 1,2-DBE 10 ng/ml 1,2-DBE 50 ng/ml 1,2-DBE 100 ng/ml 1,2-DBE 500 ng/ml 1,2-DBE 1000 ng/ml 1,2-DBE 10 ng/ml 1,1,2,2-TTCE 50 ng/ml 1,1,2,2-TTCE 100 ng/ml 1,1,2,2-TTCE 250 ng/ml 1,1,2,2-TTCE 500 ng/ml 1,1,2,2-TTCE 1000 ng/ml 1,1,2,2-TTCE 
Treatment
None 0.5% DMSO 1 Hg/ml 3-MCA 2.5 ng/ml 3-MCA 1 Hg/ml 3-MCA + 100 ng/ml TPA 1 Hg/ml 3-MCA + 0.1 ng/ml 1,2-DBE 1 Hg/ml 3-MCA + 1 ng/ml 1,2-DBE 1 Hg/ml 3-MCA + 10 ng/ml 1,2-DBE 1 Hg/ml 3-MCA + 50 ng/ml 1,2-DBE 1 Hg/ml 3-MCA + 100 ng/ml 1,2-DBE 1 Hg/ml 3-MCA + 500 ng/ml 1,2-DBE 1 Hg/ml 3-MCA + 1000 ng/ml 1,2-DBE 1 Hg/ml 3-MCA + 10 ng/ml 1,1,2,2-TTCE 1 Hg/ml 3-MCA + 50 ng/ml 1,1,2,2-TTCE 1 u.g/ml 3-MCA + 100 ng/ml 1,1,2,2-TTCE 1 Hg/ml 3-MCA + 250 ng/ml 1,1,2,2-TTCE 1 Hg/ml 3-MCA + 500 ng/ml 1,1,2,2-TTCE 1 Hg/ml 3-MCA + 1000 ng/ml 1,1,2,2-TTCE Halogenated compounds for their large use and environmental persistence can lead to an extensive human exposure (18) . Understanding their role in the carcinogenic process may be important to better evaluate risks for humans. Haloethanes, particularly chloroethanes, have been suggested to cause tumourigenesis by an indirect cytotoxic mechanism, even if a variety of short-term studies have also demonstrated their ability to act as genotoxic agents under appropriate conditions (14) .
Data from short-term tests are also available for 1,2-DBE and 1,1,2,2-TTCE (Table VI) . Both of them resulted mutagenic in the Ames test and gave positive results in other bacteria 228 and eukaryotic endpoints, including in vivo binding to nucleic acids in rodents and the ability to react covalently with exogenous DNA in vitro (1-3,5-8). Both of them require metabolic activation to produce reactive intermediates (18) . The main metabolic bioactivating pathway seems to be dependent on GSH transferases through GSH-conjugation, but oxidative steps catalyzed by P-450 dependent mixed function oxidase system (MFO) also play a role (18) (19) (20) (21) . The main DNA adduct from 1,2-DBE metabolism has been identified as a product of GSH-conjugation (19) and MFO mediated pathway has been suggested to affect mainly detoxifying steps.
Despite the similar behaviour as genotoxic agents, 1,2-DBE Table V . Promoting effects of 1,2-DBE and 1, Treatment None 0.5 % DMSO 1 Hg/ml 3-MCA 2.5 ng/ml 3-MCA 1 ng/ml 3-MCA + 100 ng/ml TPA 1 Hg/ml 3-MCA + 0.1 ng/ml 1,2-DBE 1 ng/ml 3-MCA + 1 ng/ml 1,2-DBE 1 ng/ml 3-MCA + 10 ng/ml 1,2-DBE 1 |ig/ml 3-MCA + 50 ng/ml 1,2-DBE 1 ng/ml 3-MCA + 100 ng/ml 1,2-DBE 1 ng/ml 3-MCA + 500 ng/ml 1,2-DBE 1 ng/ml 3-MCA + 1000 ng/ml 1,2-DBE 1 ng/ml 3-MCA + 10 ng/ml 1,1,2,2-TTCE 1 ng/ml 3-MCA + 50 ng/ml 1,1,2,2-TTCE 1 ng/ml 3-MCA + 100 ng/ml 1,1,2,2-TTCE 1 ng/ml 3-MCA + 250 ng/ml 1,1,2,2-TTCE 1 ng/ml 3-MCA + 500 ng/ml 1,1,2,2-TTCE 1 ng/ml 3-MCA + 1000 ng/ml 1,1,2,2-TTCE Significantly different from control (DMSO-treated cells) (P < 0.01) using distribution-free Mann-Whitney unpaired r-test. Significantly different from control (DMSO-treated cells) (P < 0.01) at the comparison of Poisson rates. 'Significantly different from 1 ng/m' 3-MCA-treated plates (P < 0.01) using distribution-free Mann-Whitney unpaired Mest.
•Significantly different from 1 ng/ml 3-MCA-treated plates (P < 0.01) at the comparison of Poisson rates.
•Significantly different from 1 ng/ml 3-MCA-treated plates (P < 0.05) at the comparison of Poisson rates. is a more potent carcinogen than 1,1,2,2-TTCE (Table VII) . Also the ability of 1,2-DBE to transform BALB/c 3T3 cells is greater. The comparison of the oncogenic potency of the two haloalkanes, of their transforming ability and of in vivo and in vitro reactivity towards DNA, from data reported in Table VII , highlights strong differences in ability to induce tumours in vivo as well as to transform BALB/c 3T3 cells in vitro. Both the oncogenic potency index (OPI) of 1,2-DBE, calculated according to Parodi et al. (22) , and the transformation frequency index (TFI) are 5.5 times higher than those calculated for 1,1,2,2-TTCE. By contrast, the indices related to the ability to react covalently with DNA, i.e. the in vivo covalent binding index (CBI) and the in vitro microsome-and cytosol-mediated binding index (MCMBI), show that 1,1,2,2-TTCE is more reactive in both in vivo and in vitro binding tests. This apparent discrepancy may be explained by assuming that 1,2-DBE exerts any promoting effects and that the contribution of non-genotoxic events is as strong or even greater than that of genotoxic events. Moreover, cells transformed by 1,2-DBE or 1,1,2,2-TTCE acquire a fully malignant phenotype (23, 24) . They can grow in soft agar, are "Oncogenic potency index calculated according to Parodi et al. (22) . See references (6) and (8).
•"Covalent binding index (CBI) calculated according to Lutz (9) on in vivo binding extent to liver DNA in mouse. See references (6), (7) and (8) . icrosome-and cytosol-mediated binding index calculated on the in vitro binding extent to calf thymus DNA. See references (6), (7) and (8).
••Transformation frequency calculated on the number of transformed cells/ no. of cell at risk. See references (10) and (11). Invasive index calculated on the no. of cells capable of penetrating a basal reconstituted membrane. See references (23) and (24) . tumourigenic when injected into animals, have metastatic properties and the ability to penetrate a reconstituted basal membrane. All these characteristics of malignancy, especially the invasive capacities, are more evident in 1,2-DBE transformed cells (23, 24) .
For several years attention has been paid to compounds which may be considered weak initiators or to compounds that do not exert any genotoxic activity, but which can still act as very effective promoters of the carcinogenesis process (17, 25) . These compounds are thought to play a role in tumour progression probably by inducing non-genotoxic (epigenetic) events.
BALB/c 3T3 cells can successfully be transformed both by genotoxic and non genotoxic compounds and they offer a suitable model to study the interaction of genotoxic and nongenotoxic events at molecular as well as at cellular levels. One of the disadvantages of the BALB/c 3T3 cell transformation model is represented by the reduced metabolizing capacities of the cells as a consequence of the immortalization process (26) . This problem can be circumvented by adding an exogenous source of metabolizing enzymes such as S9 fraction from rat liver and a NADPH regenerating system (S9-mix). S9-mix supplementation mainly supports the oxidative pathway catalyzed by the mixed function oxidase system rather than the GSH transferase mediated pathway. Also, the S9:substrate ratio affects the production of different types of metabolites. The addition of S9-mix also increases the transformation frequency in cells treated with 1,1,2,2-TTCE at lower dosages. On the contrary, the transformation rate in 1,2-DBE treated cells is lowered in the presence of S9-mix probably because the production of bromoacetaldehyde, the toxic but readily detoxified metabolite of 1,2-DBE, is increased. It is tempting to speculate that the endogenous metabolism of BALB/c 3T3 is sufficient to produce 'active' metabolite(s) capable of transforming cells and also of inducing promoting effects.
Metabolic changes are believed to be responsible for nonlinear relationships between the administered chemical and carcinogenic response (27) . Although promotion mechanisms are assumed to be threshold mediated or non linear, the shape of dose-response curve is a result of different effects which the administered chemical exerts on cell processes including metabolic processes (activation, deactivation, detoxification), biochemical processes (DNA damage and repair), growth processes (e.g. relationship between extent of cytotoxicity and increase of proliferation rate) (28) . In the BALB/c 3T3 model, 1,2-DBE can enhance the expansion of cells initiated by MNNG or 3-MCA by a selective growth process that is linear only within the lowest assayed dosages, approaching the lowdose linear model for carcinogenic risk (28) . Well-known promoters, such as the phorbol esters TPA or phorbol-12,13-didecanoate, also enhance 3-MCA-induced cell transformation in a dose-related manner, up to 100 ng/ml, and the shape of the dose-response curve is similar to that of 1,2-DBE (29) .
Data here reported strongly suggest that the differences between 1,2-DBE and 1,1,2,2-TTCE behaviours as transforming as well as oncogenic agents might be due to strong promoting effects exerted by 1,2-DBE. They also confirm that the BALB/c 3T3 cell transformation test is the most suitable in vitro model to study both genotoxic and nongenotoxic compounds.
